Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious ...

Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among ...

The firm saw an improvement in progression-free survival for patients on the ivonescimab regimen and a trend toward improved overall survival.

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Stephanie Walker was diagnosed with metastatic breast cancer (MBC) nearly a decade ago — an experience she says transformed ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

Standard medical practice is to not test men who have a life expectancy of less than 10 years for prostate cancer.

A drug, Keytruda, one of the world's most effective cancer medications, promises to transform treatment by delivering ...

“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary ...